SITC Archive Library

Presentation slides and video from the 2021-2022 Advances in Cancer Immunotherapy^™ Series - A Focus on Cellular Therapies and T Cell Engagers held virtually on December 18, 2021 are available here.

Program Organizers

• Sairah Ahmed, MD – The University of Texas MD Anderson Cancer Center
• Umar Farooq, MD – University of Iowa
• Armin Ghobadi, MD – Washington University School of Medicine
• Yi Lin, MD, PhD – Mayo Clinic

Program Summary

Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are half-day innovative programs will have the opportunity for in-depth training in immunotherapy treatment for a variety of topics from leaders in this specific field. The ACI program also featured a discussion of closed cases submitted from attendees to hear guidance and insights from expert faculty. 

Program Learning Objectives 

• Describe the mechanisms of cell therapies and T cell engagers.
• Summarize recent updates in the use of cell therapies and T cell engagers clinically and toxicity management for key disease states.
• Outline common toxicities with cell therapies and T cell engagers and their management.
• Identify unique institutional resources required for the appropriate use of cell therapies.

Please note on-demand recordings are not available for continuing education credits.

#Tcells#Myeloma#Lymphoma#BispecificAntibodies#PresentationSlides
#Video#AdvancesinCancerImmunotherapy(ACI)#2021